Krsnaa Diagnostics Limited (KRSNAA) Earnings Call Transcripts

14 earnings calls from February 2023 to May 26, 2026

NSEI IN Health Care Health Care Providers and Services

Krsnaa Diagnostics Limited's Latest Earnings Call - Q4 FY2026

In Q4 FY '26, Krsnaa Diagnostics Limited reported revenues of approximately INR 1,926 million, reflecting a year-on-year growth of 4%. The company achieved a full-year revenue of INR 7,728 million, up from INR 7,171 million in the previous year. Notably, Krsnaa's PAT for the quarter surged over 101% year-on-year to INR 417 million, contributing to a full-year PAT of INR 1,014 million. Management maintained a cautious outlook for FY '27, projecting revenue contributions from newly established operations in Rajasthan to be between INR 100 crores to INR 150 crores, signaling a more conservative approach to growth expectations.

Reported metrics

MetricValueContext
Q4 Revenue INR 1,926 million (beat) vs INR 1,850 million est, +4% YoY
Full-Year Revenue INR 7,728 million (beat) vs INR 7,171 million last year, +8% YoY
Q4 PAT INR 417 million (beat) vs INR 207 million last year, +101% YoY
Full-Year PAT INR 1,014 million (beat) vs INR 776 million last year, +30% YoY
EBITDA Margin 29% (positive) vs 27.81% last year
CapEx for FY '27 INR 5,000 million (neutral) includes ongoing and new projects

Guidance from management

Management expects revenue contributions from Rajasthan to be between INR 100 crores to INR 150 crores in FY '27, maintaining a conservative outlook on growth due to ramp-up challenges.

What management said

So in this quarter, there was no contribution of Rajasthan. We were all in the case of establishing the labs and the collection centers. We see Rajasthan contribution coming in from Q1 FY '27. The revenues have started coming up. The entire installation is expected to be completed majorly within Q1 and some bit of it flowing into Q2. So by Q2, we expect all the installations to be completed.
— Yash Mutha, Q4 FY2026 earnings call
So from an aspiration and the project value perspective, the number that we quoted earlier was good. It is just that considering the ramp up here and from our experience, we'd like to have a conservative approach.
— Yash Mutha, Q4 FY2026 earnings call

What analysts pressed on

Analysts expressed concerns regarding the slower-than-expected revenue growth and project execution delays, particularly in Maharashtra and Karnataka. There were questions about the sustainability of margins and the impact of government changes on receivables.

Main topics on the call

Read the full Krsnaa Diagnostics Limited transcript (Q4 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About Krsnaa Diagnostics Limited

Krsnaa Diagnostics Limited (KRSNAA) is a publicly listed company in the Health Care Providers and Services industry, within the Health Care sector. It trades on NSEI and is based in IN. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 14 calls on record spanning February 14, 2023 to May 26, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 14 Krsnaa Diagnostics Limited earnings call transcripts on record, spanning February 14, 2023 to May 26, 2026. Based on this history, Krsnaa Diagnostics Limited reports quarterly. The most recent call on file is dated May 26, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
KRSNAA
Exchange
NSEI
Country
IN
Sector
Health Care
Industry
Health Care Providers and Services
Calls on record
14
First call
February 14, 2023
Most recent
May 26, 2026
Reporting cadence
quarterly
Quarter Date
Q4 FY2026 May 26, 2026 Read transcript
Q3 FY2026 Feb 6, 2026 Read transcript
Q2 FY2026 Nov 10, 2025 Read transcript
Q1 FY2026 Aug 12, 2025 Read transcript
Q4 FY2025 May 13, 2025 Read transcript
Q3 FY2025 Feb 13, 2025 Read transcript
Q2 FY2025 Oct 28, 2024 Read transcript
Q1 FY2025 Aug 7, 2024 Read transcript
Q4 FY2024 May 21, 2024 Read transcript
Q3 FY2024 Feb 13, 2024 Read transcript
Q2 FY2024 Nov 6, 2023 Read transcript
Q1 FY2024 Aug 17, 2023 Read transcript
Q4 FY2023 May 29, 2023 Read transcript
Q3 FY2023 Feb 14, 2023 Read transcript